期刊文献+

肺血栓栓塞症大鼠血浆尿激酶型纤溶酶原激活物及其受体的动态变化及其意义 被引量:1

Dynamic Changes and Significance of Plasma Urokinase-Type Plasminogen Activator and its Receptor in Rats after Pulmonary Thromboembolism
下载PDF
导出
摘要 目的观察大鼠肺血栓栓塞症(PTE)后不同时间血浆尿激酶型纤溶酶原激活物(uPA)和尿激酶型纤溶酶原激活物受体(uPAR)的动态变化,并探讨两者与血栓自溶率的相关性。方法经颈外静脉注入加热125I-标记纤维蛋白原自体血栓,复制大鼠PTE模型,随机分组如下:1)正常对照组;2)PTE组:又分为PTE 4 h组(PTE 4 h)、PTE 24 h组(PTE 24 h)、PTE 3 d组(PTE 3d)、PTE 5 d组(PTE 5 d),即分别在造模成功后观察4 h2、4 h3、d、5 d后处死小鼠,留取血浆标本测定uPA、uPAR的水平;留取左肺观察肺组织病理改变;留取心脏、肺脏、全血以计算血栓自溶率。结果血浆uPA、uPAR水平在PTE后4 h略有上升(P>0.05),PTE后24 h明显增加(P<0.05),3 d时最高(P<0.01),5 d时开始下降,但仍明显高于正常对照组(uPAP<0.05,uPARP<0.01);PTE后4 h组、24 h组、3 d组血浆uPA质量浓度与血栓自溶率正相关(4 hr=0.758,P<0.05;24 hr=0.764,P<0.05;3 dr=0.778,P<0.05),血浆uPAR质量浓度与血栓自溶率正相关(4 hr=0.701,P<0.05;24 hr=0.764,P<0.05;3 dr=0.777,P<0.05)。肺组织病理改变:PTE后4 h有少量继发血栓形成,血栓及血管壁内可见白细胞浸润;PTE后3 d、5 d见注入的血凝块明显溶解,代之以新形成的血栓。结论PTE后血浆uPA、uPAR水平增加,促进内源性纤维蛋白溶解。 Objective To observe the dynamic changes of urokinase-type plasminogen activator (uPA) and its receptor (uPAR) in rats after pulmonary thromboembolism(PTE) and their relationship to spontaneous thrombolysis rate. Methods PTE was induced in Male Sprague Dawley (SD) rats through injecting heated ^125iodine-labeled fibrinogen autologous thromboembolic into external jugular veins. Thirty five rats were randomly assigned into following groups (each 7) : 1 ) Healthy eontrd group; 2) VIE group including PTE 4 h group, PTE 24 h subgroup,PTE 3 d subgroup, PTE 5 d subgroup. The rats were separately sacrificed at 4 h, 24 h, 3 d, 5 d after the PTE model was successfully made. Plasma samples were extrated and reserved for analysis of urokinase-type plasminogen activator (uPA) and its receptor (uPAR),so were he.arts, lungs and whole blood for spontaneous thrombolysis rate. Results 1) Plasma concentrations of uPA and uPAR elevated after PTE(24 h P 〈 0.05 ; 3 d P 〈 0.01 ; PTE 5 d uPA P 〈 0.05, uPAR P 〈 0.01 ) and reacbed a peak valuein PTE 3 d group, then began to decrease in PTE 5 d subgroup. Plasma concentration of uPA was positively correlated with spontaneous thro,bolysis rate after PTE in 4 h, 24 h, 3 d subgroups(4 h r=0. 758, P〈 0.05; 24 h r=0. 764, P〈 0.05; 3 d r=0.778, P〈0.05), sowas plasma uPAR(4 h r=0.701, P〈0.05; 24 h r=0.764, P〈0.05; 3 d r=0.777, P〈 0.05). Histopathological results of the lung: Secondary thrombosis and infiltration of leukocyte in thrornhus and vascular wall was observed in VIE 4 h subgroup. The injected clot was obviously dissolved in PTE 3 d and 5 d subgroup replaced by secondary thrombus. Conclusion 1 ) Plasma levels of endogenous uPA and uPAR are increased at different time points after PTE which promote endogenous fibrinolysis.
出处 《首都医科大学学报》 CAS 2006年第1期5-8,共4页 Journal of Capital Medical University
基金 北京市科委计划项目(H030930020430)资助项目
  • 相关文献

参考文献9

  • 1Kroon M E,Koolwijk P,Vermere M A,et al.Vascular endothelial growth factor receptor in human endothelial cells via protein kinase C activation[J].Thrombo Haemost,2001,85:296-302.
  • 2Langer D J,Kuo A,Kariko K,et al.Regulation of the endothelial cell urokinase-type plasminogen activator receptor.Evidence for cyclic AMP-dependent and protein kinase C-dependent pathways[J].Circ Res,1993,72:330-340.
  • 3Jauc C,Pannell R,Anforsso F,et al.Platelet associated uPA up-regalates uPA synthsesis by endothelial cells[J].Thrombo Haemost,2002,88:517-523.
  • 4Li H Z,Zhang J,Jiang Y P,et al.Urokinase-type plasminogen activator up-regulates its own expression by endothelial cells and monocytes via uPAR pathway[J].Thromb Res,2001,103:221-232.
  • 5梁心平,刘秀文,汤仲明.^125I—血栓致兔肺栓塞模型评价药物溶栓作用方法的改进和应用[J].解放军药学学报,2001,17(1):14-18. 被引量:15
  • 6Lijnen H R,Stassen J M,Collen D.Comparative thrombolytic properties of bolus injections and continuous infusions of a chimeric (t-PA/uPA) plasminogen activator in a hamster pulmonary embolism model[J].Blood,1991,l78:125-131.
  • 7Collen D,Stassen J,Verstraete M.Thombolysis with human extrinsic (tissue-type)plasminogen activator in rabbits with experimental jugular vein thrombosis.Effector of molecular form and dose of activator,age of the thrombus and route of administration[J].J Clin Invest,1983,71:368.
  • 8Moir E,Booth N A,Bennett B,et al.Polymorphonuclear leucocytes mediate endogenous thrombus lysis via a uPA-dependent mechanism[J].Br J Haematol,2001,113:72-80.
  • 9Zhou H M,Nichols A,Meda P,et al.Urokinase-type plasminogen activator and its receptor synergize to promote pathogenic proteolysis[J].EMBO J,2000,19:4817-4826.

二级参考文献4

共引文献14

同被引文献15

  • 1李家泰.临床药理学[M].2版.北京:人民卫生出版社,1998:1223.
  • 2James ED. Pulmonary embolism: what have we learned since vir- chow[J] ? Chest,2002,122(5) :1801 - 1817.
  • 3Lijnen HR, Stassen JM, CoHen D. Comparative thrombolytic prop- erties of bolus injections and continuous infusions of a ehimeric (t-PA/u-PA) plasminogen activator in a hamster pulmonary em- bolism model [ J ]. Blood, 1991,178 ( 1 ) : 125 - 131.
  • 4Li HZ, Zhang J, Jiang YP, et al. Urokinase-type plasminogen acti- vator up-regulates its own expression by endothelial cells and monocytes via u-PAR pathway[J]. Thromb Res,2001,103 ( 3 ) : 221 - 232.
  • 5Sasaki K, Moriyama S, Tanaka Y, et al. The transport of 125 I-la- beled human high molecular weight umkinase across the intestinal tract in a dog model with stimulation of synthesis and/or release of plasminogen activators [ J ]. Blood, 1985,66 ( 1 ) :69 - 75.
  • 6Toki N, Sumi H, Sasaki K, et al. Transport of urokinase across the intestinal tract of normal human subjects with stimulaton of syn- thesis and/or release of urokinase-type proteins [ J ]. J Clin In- vest, 1985,75 (4) : 1212 - 1222.
  • 7Sumi H, Seiki M, Morimoto N, et al. Plasma fibrinolysis intraduo- denal administration of urokinase in rats [ J ]. Enzyme, 1985,33 (3) :121 -127.
  • 8Langer DJ, Kuo A, Kariko K, et al. Regulation of the endothelial cell urokinase-type plasminogen activator receptor. Evidence for cyclic AMP-dependent and protein kinase C-dependent pathways [J]. Circ Res,1993,72(2) :330 -340.
  • 9Moir E, Booth NA, Bennett B, et al. Polymorphonuclear leucocytes mediate endogenous thrombus lysis via a u-PA-dependent mecha- nism[ J]. Br J Haemato1,2001,113 ( 1 ) :72 - 80.
  • 10Zhou HM, Nichols A, Meda P, et al. Urokinase-type plasminogen activator and its receptor synergize to promote pathogenic proteol- ysis[J]. EMBO J,2000,19(17) :4817 -4826.

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部